Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 318

1.

Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer.

Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y.

Int J Urol. 2020 Jan 19. doi: 10.1111/iju.14179. [Epub ahead of print]

PMID:
31957164
2.

A long-term survivor of recurrent esophagogastric junction adenocarcinoma treated with multidisciplinary therapy: a case report.

Tanaka T, Arigami T, Uenosono Y, Yanagita S, Matsushita D, Okubo K, Kijima T, Uchikado Y, Kita Y, Mori S, Sasaki K, Omoto I, Kurahara H, Maemura K, Ishigami S, Natsugoe S.

Surg Case Rep. 2020 Jan 9;6(1):13. doi: 10.1186/s40792-020-0776-5.

PMID:
31919764
3.

METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer.

Yoshida S, Takahara T, Ishii C, Arita Y, Waseda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y.

Clin Genitourin Cancer. 2019 Dec 14. pii: S1558-7673(19)30383-0. doi: 10.1016/j.clgc.2019.12.010. [Epub ahead of print]

PMID:
31902713
4.

Comparison of HER2 Status Before and After Trastuzumab-based Chemotherapy in Patients With Advanced Gastric Cancer.

Kijima T, Arigami T, Uenosono Y, Hiraki T, Yanagita S, Matsushita D, Okubo K, Shimonosono M, Ishigami S, Maemura K, Tanimoto A, Natsugoe S.

Anticancer Res. 2020 Jan;40(1):75-80. doi: 10.21873/anticanres.13927.

PMID:
31892554
5.

Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy.

Kijima T, Tanaka H, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.

Clin Genitourin Cancer. 2019 Dec 4. pii: S1558-7673(19)30356-8. doi: 10.1016/j.clgc.2019.11.005. [Epub ahead of print]

PMID:
31883941
6.

Clinical utility of FDG-PET/CT for post-surgery surveillance of malignant pleural mesothelioma - Comparison with contrast-enhanced CT.

Kitajima K, Hashimoto M, Katsuura T, Kondo N, Minami T, Kuribayashi K, Hasegawa S, Kijima T, Yamakado K.

Oncotarget. 2019 Nov 26;10(63):6816-6828. doi: 10.18632/oncotarget.27324. eCollection 2019 Nov 26.

7.

Right lower lobectomy for an aberrant mediastinal inferior lobar artery.

Nakamura A, Okumura Y, Hashimoto M, Kondo N, Shibata E, Kijima T, Hasegawa S.

Ann Thorac Surg. 2019 Nov 28. pii: S0003-4975(19)31759-X. doi: 10.1016/j.athoracsur.2019.10.021. [Epub ahead of print]

PMID:
31786288
8.

Esophageal 3D organoids of MPV17-/- mouse model of mitochondrial DNA depletion show epithelial cell plasticity and telomere attrition.

Guha M, Srinivasan S, Sheehan MM, Kijima T, Ruthel G, Whelan K, Tanaka K, Klein-Szanto A, Chandramouleeswaran PM, Nakagawa H, Avadhani NG.

Oncotarget. 2019 Oct 22;10(58):6245-6259. doi: 10.18632/oncotarget.27264. eCollection 2019 Oct 22.

9.

Types of surgery post-neoadjuvant chemotherapy for pleural mesothelioma.

Kuribayashi K, Doi H, Kijima T.

Expert Rev Respir Med. 2019 Dec;13(12):1189-1194. doi: 10.1080/17476348.2019.1679119. Epub 2019 Oct 12.

PMID:
31596628
10.

Population Genetics and Molecular Evolution of DNA Sequences in Transposable Elements. II. Accumulation of Variation and Evolution of a New Subfamily.

Iwasaki WM, Kijima TE, Innan H.

Mol Biol Evol. 2019 Oct 3. pii: msz220. doi: 10.1093/molbev/msz220. [Epub ahead of print]

PMID:
31580443
11.

EphA2 inhibition suppresses proliferation of small-cell lung cancer cells through inducing cell cycle arrest.

Ishigaki H, Minami T, Morimura O, Kitai H, Horio D, Koda Y, Fujimoto E, Negi Y, Nakajima Y, Niki M, Kanemura S, Shibata E, Mikami K, Takahashi R, Yokoi T, Kuribayashi K, Kijima T.

Biochem Biophys Res Commun. 2019 Nov 19;519(4):846-853. doi: 10.1016/j.bbrc.2019.09.076. Epub 2019 Sep 24.

PMID:
31558317
12.

Development of a Novel Prognostic Risk Classification System for Malignant Pleural Mesothelioma.

Doi H, Kuribayashi K, Kitajima K, Yamakado K, Kijima T.

Clin Lung Cancer. 2020 Jan;21(1):66-74.e2. doi: 10.1016/j.cllc.2019.08.003. Epub 2019 Aug 30.

PMID:
31551134
13.
14.

Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L).

Kimura T, Kawaguchi T, Chiba Y, Yoshioka H, Watanabe K, Kijima T, Kogure Y, Oguri T, Yoshimura N, Niwa T, Kasai T, Hayashi H, Ono A, Asai K, Tanaka H, Yano S, Yamamoto N, Nakanishi Y, Nakagawa K.

Jpn J Clin Oncol. 2019 Oct 1;49(10):947-955. doi: 10.1093/jjco/hyz088.

PMID:
31242302
15.

Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor.

Yoshida S, Takahara T, Arita Y, Ishii C, Uchida Y, Nakagawa K, Toda K, Sakamoto T, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Yoshimura R, Fujii Y.

Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):376-381. doi: 10.1016/j.ijrobp.2019.06.011. Epub 2019 Jun 12.

PMID:
31201896
16.

Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT).

Okada M, Kijima T, Aoe K, Kato T, Fujimoto N, Nakagawa K, Takeda Y, Hida T, Kanai K, Imamura F, Oizumi S, Takahashi T, Takenoyama M, Tanaka H, Hirano J, Namba Y, Ohe Y.

Clin Cancer Res. 2019 Sep 15;25(18):5485-5492. doi: 10.1158/1078-0432.CCR-19-0103. Epub 2019 Jun 4.

PMID:
31164373
17.

Arthroscopic tenodesis using a bioabsorbable interference screw and soft anchor: A case series of 60 patients.

Sasaki Y, Ochiai N, Kenmoku T, Yamaguchi T, Kijima T, Hashimoto E, Ohtori S.

J Orthop Sci. 2019 May 29. pii: S0949-2658(19)30138-1. doi: 10.1016/j.jos.2019.05.005. [Epub ahead of print]

PMID:
31153740
18.

Height loss but not body composition is related to low back pain in community-dwelling elderlies: Shimane CoHRE study.

Endo T, Abe T, Akai K, Kijima T, Takeda M, Yamasaki M, Isomura M, Nabika T, Yano S.

BMC Musculoskelet Disord. 2019 May 10;20(1):207. doi: 10.1186/s12891-019-2580-6.

19.

Cytochrome c oxidase dysfunction enhances phagocytic function and osteoclast formation in macrophages.

Angireddy R, Kazmi HR, Srinivasan S, Sun L, Iqbal J, Fuchs SY, Guha M, Kijima T, Yuen T, Zaidi M, Avadhani NG.

FASEB J. 2019 Aug;33(8):9167-9181. doi: 10.1096/fj.201900010RR. Epub 2019 May 7.

PMID:
31063702
20.

Adhesion-induced chronic abdominal pain: a case report on the diagnostic value of Carnett's test.

Kijima T, Hyakudomi R, Hashimoto T, Kusaka A, Nakatani T, Ishibashi Y.

J Med Case Rep. 2019 Apr 18;13(1):93. doi: 10.1186/s13256-019-2026-7.

21.

Heat shock factor 1 (HSF1)-targeted anticancer therapeutics: overview of current preclinical progress.

Kijima T, Prince T, Neckers L, Koga F, Fujii Y.

Expert Opin Ther Targets. 2019 May;23(5):369-377. doi: 10.1080/14728222.2019.1602119. Epub 2019 Apr 7.

PMID:
30931649
22.

[A Case of Advanced Gastric Cancer Showing Pathological Complete Response after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin].

Fukuda K, Arigami T, Yanagita S, Matsushita D, Okubo K, Kijima T, Uenosono Y, Ishigami S, Natsugoe S.

Gan To Kagaku Ryoho. 2019 Mar;46(3):471-473. Japanese.

PMID:
30914587
23.

Influence of a nerve injury proximal to the suprascapular nerve on healing of repaired rotator cuff tear.

Akimoto K, Ochiai N, Hashimoto E, Sasaki Y, Nojima D, Kajiwara D, Matsuura Y, Sasaki Y, Yamaguchi T, Kijima T, Ohtori S.

J Orthop Sci. 2019 Mar 8. pii: S0949-2658(19)30056-9. doi: 10.1016/j.jos.2019.02.007. [Epub ahead of print]

PMID:
30857766
24.

Effect of geographic accessibility to primary care on treatment status of hypertension.

Okuyama K, Akai K, Kijima T, Abe T, Isomura M, Nabika T.

PLoS One. 2019 Mar 4;14(3):e0213098. doi: 10.1371/journal.pone.0213098. eCollection 2019.

25.

Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients.

Kijima T, Tanaka H, Koga F, Masuda H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.

BJU Int. 2019 Aug;124(2):242-250. doi: 10.1111/bju.14736. Epub 2019 Apr 3.

PMID:
30811784
26.

Analysis of Pleiotropic Effects of Nivolumab in Pretreated Advanced or Recurrent Non-small Cell Lung Cancer Cases.

Akano Y, Kuribayashi K, Funaguchi N, Koda Y, Fujimoto E, Mikami K, Minami T, Takahashi R, Yokoi T, Kijima T.

In Vivo. 2019 Mar-Apr;33(2):507-514. doi: 10.21873/invivo.11503.

27.

A Phase II Study of Tailored-dose S-1 Plus Carboplatin Followed by Maintenance S-1 for Advanced Squamous Cell Lung Cancer: OSAKA-LCSG 1102.

Yokoi T, Minami S, Shiroyama T, Koba T, Torii Y, Sugimoto H, Niki M, Mori M, Morimura O, Hirashima T, Komuta K, Kijima T.

Intern Med. 2019 May 15;58(10):1405-1410. doi: 10.2169/internalmedicine.1172-18. Epub 2019 Feb 1.

28.

Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer.

Shintani T, Higashisaka K, Maeda M, Hamada M, Tsuji R, Kurihara K, Kashiwagi Y, Sato A, Obana M, Yamamoto A, Kawasaki K, Lin Y, Kijima T, Kinehara Y, Miwa Y, Maeda S, Morii E, Kumanogoh A, Tsutsumi Y, Nagatomo I, Fujio Y.

Oncotarget. 2018 Dec 25;9(101):37520-37533. doi: 10.18632/oncotarget.26494. eCollection 2018 Dec 25.

29.

Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells.

Kinehara Y, Nagatomo I, Koyama S, Ito D, Nojima S, Kurebayashi R, Nakanishi Y, Suga Y, Nishijima-Futami Y, Osa A, Nakatani T, Kato Y, Nishide M, Hayama Y, Higashiguchi M, Morimura O, Miyake K, Kang S, Minami T, Hirata H, Iwahori K, Takimoto T, Takamatsu H, Takeda Y, Hosen N, Hoshino S, Shintani Y, Okumura M, Kumagai T, Nishino K, Imamura F, Nakatsuka SI, Kijima T, Kida H, Kumanogoh A.

JCI Insight. 2018 Dec 20;3(24). pii: 123093. doi: 10.1172/jci.insight.123093.

30.

Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells.

Kijima T, Nakagawa H, Shimonosono M, Chandramouleeswaran PM, Hara T, Sahu V, Kasagi Y, Kikuchi O, Tanaka K, Giroux V, Muir AB, Whelan KA, Ohashi S, Naganuma S, Klein-Szanto AJ, Shinden Y, Sasaki K, Omoto I, Kita Y, Muto M, Bass AJ, Diehl JA, Ginsberg GG, Doki Y, Mori M, Uchikado Y, Arigami T, Avadhani NG, Basu D, Rustgi AK, Natsugoe S.

Cell Mol Gastroenterol Hepatol. 2018 Sep 14;7(1):73-91. doi: 10.1016/j.jcmgh.2018.09.003. eCollection 2019.

31.

Development of the Japanese version of the general practice assessment questionnaire: measurement of patient experience and testing of data quality.

Kijima T, Akai K, Matsushita A, Hamano T, Onoda K, Yano S, Nabika T, Ishibashi Y, Kumakura S.

BMC Fam Pract. 2018 Nov 28;19(1):181. doi: 10.1186/s12875-018-0873-8.

32.

Incidence and predictive factors of hypoglycemia after pheochromocytoma resection.

Araki S, Kijima T, Waseda Y, Komai Y, Nakanishi Y, Uehara S, Yasuda Y, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Nakano Y, Yoshimoto T, Uchida T, Fujii Y.

Int J Urol. 2019 Feb;26(2):273-277. doi: 10.1111/iju.13864. Epub 2018 Nov 22.

PMID:
30467902
33.

Adherent Perinephric Fat in Asian Patients: Predictors and Impact on Perioperative Outcomes of Partial Nephrectomy.

Kawamura N, Saito K, Inoue M, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y.

Urol Int. 2018;101(4):437-442. doi: 10.1159/000494068. Epub 2018 Oct 18.

PMID:
30343303
34.

Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients.

Osa A, Uenami T, Koyama S, Fujimoto K, Okuzaki D, Takimoto T, Hirata H, Yano Y, Yokota S, Kinehara Y, Naito Y, Otsuka T, Kanazu M, Kuroyama M, Hamaguchi M, Koba T, Futami Y, Ishijima M, Suga Y, Akazawa Y, Machiyama H, Iwahori K, Takamatsu H, Nagatomo I, Takeda Y, Kida H, Akbay EA, Hammerman PS, Wong KK, Dranoff G, Mori M, Kijima T, Kumanogoh A.

JCI Insight. 2018 Oct 4;3(19). pii: 59125. doi: 10.1172/jci.insight.59125.

35.

Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy.

Kawamura N, Yokoyama M, Tanaka H, Nakayama T, Yasuda Y, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.

Int J Urol. 2019 Jan;26(1):113-118. doi: 10.1111/iju.13799. Epub 2018 Sep 25.

36.

[A Case of Mediastinal Small Cell Lung Cancer in a Patient Receiving Mechanical Ventilation Who Was Successfully Treated with Chemotherapy and Finally Extubated].

Koba T, Hirata H, Kijima T, Naito Y, Hamaguchi M, Suga Y, Kuroyama M, Koyama S, Iwahori K, Takimoto T, Nagatomo I, Takeda Y, Kida H.

Gan To Kagaku Ryoho. 2018 Sep;45(9):1335-1337. Japanese.

PMID:
30237376
37.

Selecting suitable chemotherapies for PD-1/PD-L1 blockade to optimize the tumor immune microenvironment.

Koyama S, Nagatomo I, Kijima T, Kumanogoh A.

Oncotarget. 2018 Aug 24;9(66):32552-32553. doi: 10.18632/oncotarget.26028. eCollection 2018 Aug 24. No abstract available.

38.

Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.

Nakayama T, Saito K, Kumagai J, Nakajima Y, Kijima T, Yoshida S, Kihara K, Fujii Y.

Clin Genitourin Cancer. 2018 Dec;16(6):e1151-e1158. doi: 10.1016/j.clgc.2018.07.027. Epub 2018 Aug 11.

PMID:
30213543
39.

Early-stage Clinical Characterization of Malignant Pleural Mesothelioma.

Negi Y, Kuribayashi K, Funaguchi N, Doi H, Mikami K, Minami T, Takuwa T, Yokoi T, Hasegawa S, Kijima T.

In Vivo. 2018 Sep-Oct;32(5):1169-1174. doi: 10.21873/invivo.11360.

40.

Therapeutic failure and eventual solution for skin necrosis and exposed tendon of the dorsum of the foot: A case report.

Toyoshima Y, Maeda T, Kijima T, Namiki O, Nemoto T, Inagaki K.

Clin Case Rep. 2018 Jul 1;6(8):1600-1603. doi: 10.1002/ccr3.1697. eCollection 2018 Aug.

41.

A Rapid Enrichment Technique for the Ultratrace Determination of Nickel in Water Samples Using a Nanofiber-composite Membrane Filter.

Mizuguchi H, Ishida R, Kouno Y, Tachibana T, Honda T, Kijima T, Yamamoto Y, Takayanagi T.

Anal Sci. 2018;34(8):907-912. doi: 10.2116/analsci.18P093.

42.

Double cancer comprising malignant pleural mesothelioma and squamous cell carcinoma of the lung treated with radiotherapy: A case report.

Negi Y, Kuribayashi K, Doi H, Funaguchi N, Koda Y, Fujimoto E, Mikami K, Minami T, Yokoi T, Kijima T.

Mol Clin Oncol. 2018 Aug;9(2):181-186. doi: 10.3892/mco.2018.1650. Epub 2018 Jun 11.

43.

Utility of polaprezinc in reducing toxicities during radiotherapy: a literature review.

Doi H, Kuribayashi K, Kijima T.

Future Oncol. 2018 Aug;14(19):1977-1988. doi: 10.2217/fon-2018-0021. Epub 2018 Aug 3. Review.

PMID:
30074413
44.

Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiation Therapy.

Tanaka H, Yoshida S, Koga F, Toda K, Yoshimura R, Nakajima Y, Sugawara E, Akashi T, Waseda Y, Inoue M, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.

Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1408-1416. doi: 10.1016/j.ijrobp.2018.06.030. Epub 2018 Jun 28.

PMID:
29960059
45.

Successful Treatment of Pulmonary Pleomorphic Carcinoma with Nivolumab: A Case Report.

Fujimoto E, Yokoi T, Mikami K, Kanemura S, Shibata E, Horio D, Koda Y, Negi Y, Akano Y, Tada A, Minami T, Kuribayashi K, Kijima T.

Case Rep Oncol. 2018 May 31;11(2):336-340. doi: 10.1159/000489392. eCollection 2018 May-Aug.

46.

The Direct Oblique Method: A New Gold Standard for Bronchoscopic Navigation That is Superior to Automatic Methods.

Miyake K, Morimura O, Inoue T, Yoshida K, Nagatomo I, Kijima T, Kumanogoh A.

J Bronchology Interv Pulmonol. 2018 Oct;25(4):305-314. doi: 10.1097/LBR.0000000000000512.

PMID:
29901530
47.

Histological analysis and biomechanical evaluation of fatty infiltration after rotator cuff tear and suprascapular nerve injury in a rat model.

Sasaki Y, Ochiai N, Nakajima A, Sasho T, Kenmoku T, Yamaguchi T, Kijima T, Hashimoto E, Sasaki Y, Ohtori S.

J Orthop Sci. 2018 Sep;23(5):834-841. doi: 10.1016/j.jos.2018.04.004. Epub 2018 Jun 5.

PMID:
29880227
48.

Computer-aided diagnosis of prostate cancer on magnetic resonance imaging using a convolutional neural network algorithm.

Ishioka J, Matsuoka Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Saito K, Kihara K, Numao N, Kimura T, Kudo K, Kumazawa I, Fujii Y.

BJU Int. 2018 Sep;122(3):411-417. doi: 10.1111/bju.14397. Epub 2018 Jun 7.

49.

Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer.

Koba T, Minami S, Nishijima-Futami Y, Masuhiro K, Kimura H, Futami S, Yaga M, Mori M, Kagawa H, Uenami T, Kohmo S, Otsuka T, Yamamoto S, Komuta K, Kijima T.

Cancer Chemother Pharmacol. 2018 Jul;82(1):111-117. doi: 10.1007/s00280-018-3598-4. Epub 2018 May 4.

PMID:
29728800
50.

HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation.

Kijima T, Prince TL, Tigue ML, Yim KH, Schwartz H, Beebe K, Lee S, Budzynski MA, Williams H, Trepel JB, Sistonen L, Calderwood S, Neckers L.

Sci Rep. 2018 May 3;8(1):6976. doi: 10.1038/s41598-018-25404-w.

Supplemental Content

Loading ...
Support Center